Scarica l'app Stockscreener
1.05
0.96%
0.01
Dopo l'orario di chiusura:
1.01
-0.04
-3.81%
Precedente Chiudi:
$1.04
Aprire:
$0.92
Volume 24 ore:
4.39M
Relative Volume:
0.99
Capitalizzazione di mercato:
$5.59M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+47.20%
1M Prestazione:
+30.89%
6M Prestazione:
-99.71%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.8571
$1.05
Intervallo di 1 settimana:
$0.66
$1.33
Portata 52W:
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Confronta PLRZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
1.05 | 3.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Polyrizon Plunges 11.06% Amid Market Challenges - AInvest
Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved - Benzinga
How Polyrizon Ltd. stock performs during market volatilitySmart Trading With Safety Margin - Newser
What makes Polyrizon Ltd. stock price move sharplyFree High-Accuracy Stock Picks - Newser
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon secures continued Nasdaq listing after panel hearing By Investing.com - Investing.com Nigeria
Polyrizon secures continued Nasdaq listing after panel hearing - Investing.com
Polyrizon Ltd. Secures Continued Nasdaq Listing Following Compliance Plan Implementation - Quiver Quantitative
Polyrizon Retains Nasdaq Listing Following Hearings Panel - 富途牛牛
Why Polyrizon Ltd. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors - The Globe and Mail
Polyrizon director Omer Srugo resigns; board affirms independent members - Investing.com
Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com
Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener
Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia
Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks
Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq - GlobeNewswire
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon Soars 14.55% Post Reverse Stock Split - AInvest
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Bluefield Daily Telegraph
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Polyrizon Plunge 15.4%? Pipeline Uncertainty, Market Headwinds - AInvest
Polyrizon Ltd Azioni (PLRZ) Dati Finanziari
Non sono disponibili dati finanziari per Polyrizon Ltd (PLRZ). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.40%
2.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):